Joan B Soriano is an expert in Pulmonology at Hospital Universitario de La Princesa (Spain). As of October 2026, ScienceLeadR ranks Joan B Soriano in the top 1% of experts worldwide for Coronavirus Infections, COVID-19 and Pneumonia. Joan B Soriano has authored 569 publications, the most recent in 2026, and is an investigator in 15 clinical trials. SLR score: 2,181 (community average: 125). How the SLR is computed.

LeadR Profile

2 181 ScienceLeadR Reputation 2181
Network Map

Pulmonology

Subspecialties: Public Health - Biochemistry - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2001 - 2026

Source: PubMed

Hospital Universitario de La Princesa

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 569

Citations

Citations: 137 481 1st author: 111 Last author: 82 Unique author: 13


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
PMID 42705247 — public health, global burden of disease, smoke, prevalence, risk factors, cost of illness, child
Lancet Public Health20260
Differential diagnosis of asthma and COPD: Established and emerging biomarkers and technologies.
PMID 42665061 — diagnosis, differential, biomarkers, pulmonary disease, chronic obstructive, diagnosis, asthma, physical exertion
Respir Med20260
The Fourth One is Coming: Why Spain Needs SCOPES, a New COPD Epidemiological Study in 2027.
PMID 42469063 — epidemiologic studies, pulmonary disease, chronic obstructive
Arch Bronconeumol20260
The epidemiological burden and societal cost of 14 respiratory conditions in the World Health Organization European region: systematic evidence map and economic analysis.
PMID 42376020 — mortality, lung, incidence, fibrosis, neoplasms, cystic fibrosis, lung neoplasms, influenza, human, prevalence, bronchiectasis
ERJ Open Res20262
Author Correction: Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a Global Burden of Disease Study.
PMID 42303780 — cocaine, molecular biology, global burden of disease, cost of illness, amphetamine
Nat Med Top journal20260

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Chair: 1

By phase:

N/A 13
Phase 2 1
Phase 3 1

By status:

Completed 9
Unknown 5
Terminated 1

By type:

Observational 11
Interventional 4

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 2
multicentric5to9 2
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 11

LeadR Networks

Main global connection map